• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Clin Med . The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity

tetano

Editor, Senior Moderator
J Clin Med


. 2025 Mar 12;14(6):1909.
doi: 10.3390/jcm14061909. The Prevalence of Previous Coronavirus Disease-19 in Patients with Pulmonary Thromboembolism and Its Effect on Embolism Severity

Nagihan Durmuş Koçak[SUP] 1 [/SUP], Nuri Tutar[SUP] 2 [/SUP], Gizem Çil[SUP] 3 [/SUP], Emine Afşin[SUP] 4 [/SUP], Ayşegül Şentürk[SUP] 5 [/SUP], Derya Aydın[SUP] 6 [/SUP], Buket Mermit[SUP] 7 [/SUP], Elif Torun Parmaksız[SUP] 1 [/SUP], Mustafa Çolak[SUP] 8 [/SUP], Elif Yıldırım[SUP] 9 [/SUP], Songül Özyurt[SUP] 10 [/SUP], Gülru Polat[SUP] 11 [/SUP], Elif Tanrıverdi[SUP] 12 [/SUP], İlknur Kaya[SUP] 13 [/SUP], Nur Aleyna Yetkin[SUP] 2 [/SUP], Elif Yılmazel Uçar[SUP] 3 [/SUP], Sibel Doğru[SUP] 14 [/SUP], Talat Kilic[SUP] 15 [/SUP], Hatice Arzu Uçar[SUP] 16 [/SUP], Serdar Berk[SUP] 17 [/SUP], Tuğba Çiçek[SUP] 18 [/SUP], Emine Ozsari[SUP] 4 [/SUP], Gamze Kırkıl[SUP] 19 [/SUP], Halil İbrahim Yakar[SUP] 20 [/SUP], Ersin Alkılınç[SUP] 21 [/SUP], Ali Tabaru[SUP] 22 [/SUP], Esra Yarar[SUP] 23 [/SUP], Emine Aksoy[SUP] 9 [/SUP], Burcu Akkök[SUP] 24 [/SUP], Şebnem Emine Parspur[SUP] 13 [/SUP], Ercan Kurtipek[SUP] 25 [/SUP], Fatih Uzer[SUP] 26 [/SUP], Utku Tapan[SUP] 27 [/SUP], Dildar Duman[SUP] 9 [/SUP], Dursun Tatar[SUP] 11 [/SUP], Gülistan Karadeniz[SUP] 11 [/SUP], İclal Hocanlı[SUP] 28 [/SUP], Özge Oral Tapan[SUP] 27 [/SUP], Kadir Canoğlu[SUP] 29 [/SUP], Fulsen Bozkuş[SUP] 24 [/SUP], Nevra Gullu Arslan[SUP] 30 [/SUP], Ömer Tamer Doğan[SUP] 17 [/SUP], Mahşuk Taylan[SUP] 14 [/SUP], Ayşe Pala[SUP] 31 [/SUP]



Affiliations
Abstract

Background/Objectives: The association between past coronavirus disease-19 (COVID-19) infection and pulmonary thromboembolism (PTE) is a potential research topic. We aimed to research the prevalence of previous COVID-19 infection in patients with PTE and to determine whether there is a difference in embolism severity in these cases. Methods: Study design: Multicenter, observational, cross-sectional. Patients diagnosed with PTE between 11 March 2022 and 11 March 2023 were prospectively included in this study, excluding cases with PTE along with active COVID-19, patients under the age of 18, and pregnant patients. Group 1 consisted of PTE cases with previous COVID-19, and Group 2 consisted of PTE cases without previous COVID-19. Key variables are D-Dimer level, right ventricle/left ventricle (RV/LV) ratio, simplified pulmonary embolism severity score, and treatment type. Results: A total of 1185 patients (Group 1; n = 360, Group 2; n = 825) were included in this study. The proportion of patients with RV/LV ratio > 1 on computed tomography pulmonary angiography (CTPA) was significantly high in Group 2 compared to Group 1 (27.9% vs. 19.7%, p = 0.003). In multivariate logistic regression analysis, the absence of any identifiable risk factor for PTE was found to be a 0.46-fold protective factor in the presence of previous COVID-19 (OR: 0.456 95% CI: 0.274-0.760, Wald = 9.070, df = 1, p = 0.003) and an RV/LV ratio > 1 on CTPA was found to be a 0.60-fold protective factor (OR: 0.603, 95% CI: 0.365-0.998, Wald = 3.874, df = 1, p = 0.049). Conclusions: The prevalence of previous COVID-19 infection in PTE cases was 30.4%, and 26.3% of idiopathic cases had previous COVID-19 infection. Although the parameters related to embolism severity were higher in the non-COVID-19 group, multivariate analyses revealed a 2.2-fold increased risk for idiopathic PTE and a 1.7-fold increased risk for RV/LV ratio > 1 on CTPA in patients without COVID-19 compared to those with prior COVID-19.

Keywords: COVID-19; hospital mortality; patient acuity; pulmonary embolism; risk factors.

 
Back
Top Bottom